The Racial Equity and Access Committee is a branch of the Chacruna Institute for Psychedelic Plant Medicines that endeavors to ensure that traditionally marginalized racial, ethnic, and indigenous communities have access to these healing medicines and are actively included in the field of psychedelic studies at all levels. This consortium of researchers, advocates, and activists aims to center social justice-related values in the field of psychedelic studies, broadly defined; give visibility to indigenous people’s legacies and knowledge around psychedelic plant medicines; promote the presence of people of color in the field (in conferences, events, documentaries, media interviews etc); hold the field accountable for the inclusion of diverse people in research studies, treatment trials, and policy initiatives; increase access to and availability of psychedelics in diverse communities; raise awareness of the benefits of psychedelics in diverse communities; advise providers on culturally-responsive uses of psychedelics and collaborate with researchers to design protocols that are inclusive and culturally-responsive.
Chacruna’s Inclusion, Diversity and Psychedelics Call for Articles
Chacruna’s Inclusion, Diversity and Psychedelics series addresses historic and contemporary challenges to access and inclusion in the psychedelic community, leadership, and research. In this series we explore individual, structural, and sociocultural factors that act as barriers to full inclusion, identify strategies to transform the field, and highlight calls to action for ensuring equity, dismantling oppression, and creating sustained systemic change. The series features research summaries, reflections, and strategies for increasing the inclusion of diverse people at all levels of the psychedelic revolution. The series seeks submission for original articles related to this topic.
For more information, and submissions write at: [email protected]
To read the articles of this series, click here.
Racial Equity and Access Committee
Dr. Sonya Faber graduated with a Masters in Neurobiology from Brown University after completing her undergraduate work at the University of Pennsylvania. She continued her graduate studies at New York University earning a PhD in molecular genetics with a thesis concentration in signal transduction. Over the course of the last 15 years, she has had the opportunity and privilege to contribute equally to both academic research institutes and commercial pharmaceutical development. She has worked in clinical operations for companies including, IQVIA, Covance and Sanofi-Aventis. Her interests lie in creating innovative solutions for projects which could benefit both patients and the scientific community, in part by connecting with top scientists, industry and regulatory agencies.In her academic roles, she assessed novel ideas and supported scientists in making these commercially viable while contributing to several original grants and research papers and patents. Her interest in protocol design, medical writing and project management, which she utilized in both pharma and biotech firms, included pre-clinical and clinical activities for phase II and III trials across multiple indications. She has a special interest in training the next generation of clinical researchers and has designed courses to teach scientific writing and Good Clinical Practice. Dr. Faber is member of the Board Directors of the Chacruna Institute for Psychedelic Plant Medicines and serves on Chacruna’s Racial Equity and Access Committee. Her engagement on Chacruna is on a volunteer basis and is based on her personal interest in the science of psychedelics, which has long been an interest of hers before taking her current position at Angelini Pharma. In the past two years, she has started an international collaboration with researchers at the University of Ottawa in Canada on several projects in the area of mental health disparities and social justice. She also served on the steering committee for the American Psychedelic Practitioners Association.
Jamilah R. George, M.Div., a Detroit native, singer, dancer, and actress, obtained her Bachelor’s from the University of Michigan, her Master’s from Yale University, and is now pursuing a Ph.D. in Clinical Psychology at the University of Connecticut. Jamilah serves as a MAPS-sponsored phase 3 MDMA-assisted psychotherapy co-therapist whose site focuses on treatment-resistant posttraumatic stress among people of color. She is also a member of Chacruna’s Racial Equity and Access committee. Her research interests include obsessive-compulsive and related disorders, the psychological effects of discrimination and racial trauma on people of color, and the neurological underpinnings of these disorders. Jamilah’s passion for social justice and equality issues fuels her work as she advocates for the mental and holistic wellbeing of socially disenfranchised groups, including women, people of color, impoverished domestic and international communities, and the intersections therein.
Dr. Stephanie Michael Stewart is a holistic psychiatrist who brings a spiritual, environmental, and social justice perspective to her work. After serving as Chief Resident of Psychiatry at Cedars-Sinai Medical Center, Dr. Stewart led LA County’s West Central Wellness Center where she developed innovative programs for communities of color that integrated evidence-based psychiatric treatments with complementary therapies. She then founded Worldwide Wellness, where she expanded her approach to incorporate travel, immersion in nature, Indigenous wisdom and, more recently, ketamine-assisted therapy. Dr. Stewart is currently developing a psychedelic-assisted therapy training program for psychiatric residents at historically black colleges and universities. Dr. Stewart holds a BS in Biology from Spelman College and an MD from Morehouse School of Medicine. She is a psychedelic advisor to multiple organizations in the US and Canada and is a member of Chacruna’s Racial Equity and Access Committee. She is of Black, White, and Native American descent.
Monnica T. Williams is a clinical psychologist and Associate Professor at the University of Ottawa, in the School of Psychology, where she is the Canada Research Chair in Mental Health Disparities. She is also Clinical Director of the Behavioral Wellness Clinic. Her research focuses on African American mental health, culture, and psychopathology, and she has published over 100 scientific articles on these topics. Current projects include the assessment of race-based trauma, unacceptable thoughts in OCD, improving cultural competence in the delivery of mental health care services, and interventions to reduce racism. She gives diversity trainings nationally for clinical psychology programs, scientific conferences, and community organizations. She currently is Chair of their Academic Training & Education Standards (ATES). She is also a member of the Scientific Advisory Board of the International OCD Foundation, and co-founded their Diversity Council. Dr. Williams is a member of Chacruna’s Racial Equity and Access Committee.